The invention relates to the calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9-bis[(carboxy-.k appa. O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phos phaundecan-11-ylic-acid-.kappa.N6,.kappa. N9,.kappa.011]1-oxidato(6-)]-, tetrahydrogen(MS-325) and its salts, pharmaceutical agents that contain these complexes, for the production of agents for the reduction of effects that are caused by heavy metals as well as processes for their production.

L'invention concerne le complexe de calcium de [ [ (appa 4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9-bis[(carboxy-.k. O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phos phaundecan-11-ylic-acid-.kappa.N6.kappa. N9.kappa.011]1-oxidato(6 -)]-, tetrahydrogen(MS-325) et ses sels, agents pharmaceutiques qui contiennent ces complexes, pour la production des agents pour la réduction d'effets qui sont provoqués par les métaux lourds aussi bien que des procédés pour leur production.

 
Web www.patentalert.com

< Antimicrobial vulcanized EPDM rubber articles

< Latent reactive blood compatible agents

> Controlling protein levels in eucaryotic organisms

> Mycobacterium fol A gene that encodes for the enzyme dihydrofolate reductase

~ 00069